Skip to content
Navigate to homepage - Cerba Research

Genomic For Infectious Diseases

With years of history in infectious diseases  trials, Cerba Research is dedicated to enhancing  your project with our genomic  capabilities and scientific experience. 

Cerba Research Genomic Capabilities For Infectious Diseases

We are your trusted partner for your Genomic needs in Infectious Diseases

qPCR

ddPCR

Whole Exome Sequencing

Whole Genome Sequencing

Single Cell Sequencing

RNA – sequencing

B-Cell Receptor / T-Cell Receptor Sequencing

Microbiome

Microbiome Analysis Using Next Generation Sequencing (NGS)

Next generation sequencing (NGS) allows for the simultaneous analysis of the gene’s coding for the 16S ribosomal RNA for bacterial identification and the ITS (internal Transcribe Spacer) region for the characterization of fungal species. This is possible due to hundreds of thousands of copies of DNA sequences. 

 

The obtained sequences are compared with well-known sequences of bacterial or fungal genes detailed in the Silva algorithm (97%.)

 

This novel test is performed on stool samples and allows the mapping of the intestinal bacterial and fungal flora including the species that cannot be cultivated. 

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our genomics team and see how we can help advance your research

Contact Us